These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. 2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722. Winn M; von Geldern TW; Opgenorth TJ; Jae HS; Tasker AS; Boyd SA; Kester JA; Mantei RA; Bal R; Sorensen BK; Wu-Wong JR; Chiou WJ; Dixon DB; Novosad EI; Hernandez L; Marsh KC J Med Chem; 1996 Mar; 39(5):1039-48. PubMed ID: 8676339 [TBL] [Abstract][Full Text] [Related]
45. Discovery and optimization of a novel class of orally active nonpeptidic endothelin-A receptor antagonists. Riechers H; Albrecht HP; Amberg W; Baumann E; Bernard H; Böhm HJ; Klinge D; Kling A; Müller S; Raschack M; Unger L; Walker N; Wernet W J Med Chem; 1996 May; 39(11):2123-8. PubMed ID: 8667356 [TBL] [Abstract][Full Text] [Related]
47. Blocking of the endothelin system: the development of receptor antagonists. Battistini B; Dussault P Pulm Pharmacol Ther; 1998; 11(2-3):97-112. PubMed ID: 9918742 [No Abstract] [Full Text] [Related]